What top creators are saying about Q32 Bio Inc.(QTTB)
Clinical-stage biotechnology company developing biologic therapeutics for autoimmune and inflammatory diseases.
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Q32 Bio Inc..
Top creators covering Q32 Bio Inc. (QTTB)
The 2 sources with the most insights about Q32 Bio Inc. on Kazuha.
Latest insights about Q32 Bio Inc. (QTTB)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Wednesday, September 30, 2026
The speaker had heard that people wanted to trade the stock but said he did not know much about it.
Monday, July 13, 2026
Positive Phase II results for Benpigabart in Alopecia Areata show strong efficacy and a superior safety profile compared to JAK inhibitors, with a potential $5B market opportunity.
Wednesday, September 30, 2026
The speaker had heard that people wanted to trade the stock but said he did not know much about it.
Monday, July 13, 2026
Positive Phase II results for Benpigabart in Alopecia Areata show strong efficacy and a superior safety profile compared to JAK inhibitors, with a potential $5B market opportunity.
Discussed alongside Q32 Bio Inc. (QTTB)
Other assets that creators frequently mention in the same content as Q32 Bio Inc..
Frequently asked
Which podcasters and creators cover Q32 Bio Inc. (QTTB) the most?
The most active sources covering Q32 Bio Inc. (QTTB) on Kazuha are @realmartinshkreli, @theshkrelipill. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Q32 Bio Inc. (QTTB) are on Kazuha?
Kazuha has indexed 2 AI-extracted insights about Q32 Bio Inc. (QTTB) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Q32 Bio Inc. (QTTB)?
Creators covering Q32 Bio Inc. (QTTB) most frequently also discuss NVDA, 000660, AMD, MU, MRNA. See the "Discussed alongside" section above for full asset pages.